DT4PH: Digital Twins for Personalised Healthcare

Growing the ecosystem and market for digital twins in personalised healthcare

The project
Partners

DT4PH: AI and Digital Twins in Healthcare

Our goal? Personalised computer models for disease prevention, diagnosis, and treatment.

DT4PH is a Belgian research project funded by BOSA – Belgian Federal Department of Policy & Support

The programme includes five proof-of-concept projects, and also offers an educational curriculum, ecosystem expansion, and a translational pathway.

This project will contribute to a more sustainable, efficient, and patient-centred healthcare system, while also strengthening Belgium’s position as a leader in digital healthcare within the EU.

Our Plan

Proof of concept projects

5 proof-of-concept (PoC) projects ranging from research-intensive projects to regulatory science for a wide range of end users.

Educational programs

and materials tailored for students, professionals in R&D of medical products, and professionals in regulatory or marketing roles.

Stakeholder engagement

including scientists, industries, regulatory bodies, patients and patients associations, clinicians and policymakers.

2022-2026

Duration

7

Partners

5

Proof-of-concept Projects

2M

Fundings

Proof-of-concept Projects

Small Patient Populations

Addresses the collection of data to support the effective and safe use of medicines in paediatric and poly-pharmacological patients.

Intensive Care Unit

Intensive Care Unit medicine involves a wide range of sensors and devices to measure patient state and further devices to deliver care.

Osteoarthritis

Osteoarthritis is a common and debilitating disease that affects more than 15% of the population and increasing due to an aging population.

Pharmacogenetics

Pharmacogenetics is the study of how an individual’s genetic makeup affects the response to medications.

Brain-on-Chip NeuroCAAS

Neuronal circuits reconstructed in vitro from human induced pluripotent stem cells for biomedical purposes.

Triple-B

The goal of TripleB is to develop a superior, human-relevant in vitro organ-on-chip model of the Blood-Brain Barrier.

DT4PH is a Belgian research project funded by BOSA – Belgian Federal Department of Policy & Support

Latest News

  • VPH: Ecosystem, Education, Translation
    In the first half of the DigiTwin4PH, contributions have been made to the (road)mapping and translational activities of EDITH to ensure the inclusion of the Belgian perspective in the Virtual…
  • U.Namur & FAMHP: Small Patient Populations
    It is widely recognised by all stakeholders that the collection of data to support the effective and safe use of medicines in paediatric and poly-pharmacological patients (e.g. geriatric patients) poses…
  • U.Liège: Intensive Care Unit
    Intensive care medicine is one of the most technology-laden areas of healthcare. It consumes ~1-2% of GDP (or ~10% of health budgets) in modern countries, while treating 0.1% of patients…
  • KU Leuven: osteoarthritis
    Osteoarthritis is a common and debilitating disease that affects more than 15% of the population, with increasing prevalence due to an aging population. There is significant variability between patients, and…
  • VITO: Pharmacogenetics
    Pharmacogenetics (PGx) is the study of how an individual’s genetic makeup affects his/her response to medications. Pharmacogenomics has matured into a well-established field. Today, internationally recognized consortia have issued guidelines…

Contact us

Would you like to know more about DT4PH?
Do you have any questions for us?

Contact us